HEADER OXIDOREDUCTASE 03-DEC-98 3HAD TITLE BIOCHEMICAL CHARACTERIZATION AND STRUCTURE DETERMINATION OF HUMAN TITLE 2 HEART SHORT CHAIN L-3-HYDROXYACYL COA DEHYDROGENASE PROVIDE INSIGHT TITLE 3 INTO CATALYTIC MECHANISM COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (L-3-HYDROXYACYL COA DEHYDROGENASE); COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: SCHAD; COMPND 5 EC: 1.1.1.35; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: COMPLEXED WITH NICOTINAMIDE-ADENINE-DINUCLEOTIDE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: HEART; SOURCE 6 ORGANELLE: MITOCHONDRIAL; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 OTHER_DETAILS: PROTEIN WAS EXPRESSED WITH A C-TERMINAL HEXAMERIC SOURCE 10 HISTIDINE TAG. KEYWDS OXIDOREDUCTASE, BETA OXIDATION, SCHAD, CATALYTIC ACTIVITY: L-3- KEYWDS 2 HYDROXYACYL-COA + NAD(+) = 3-OXOACYL-COA + NADH EXPDTA X-RAY DIFFRACTION AUTHOR J.J.BARYCKI,J.M.BRATT,L.J.BANASZAK REVDAT 4 13-JUL-11 3HAD 1 VERSN REVDAT 3 24-FEB-09 3HAD 1 VERSN REVDAT 2 01-APR-03 3HAD 1 JRNL REVDAT 1 12-JAN-00 3HAD 0 JRNL AUTH J.J.BARYCKI,L.K.O'BRIEN,J.M.BRATT,R.ZHANG,R.SANISHVILI, JRNL AUTH 2 A.W.STRAUSS,L.J.BANASZAK JRNL TITL BIOCHEMICAL CHARACTERIZATION AND CRYSTAL STRUCTURE JRNL TITL 2 DETERMINATION OF HUMAN HEART SHORT CHAIN L-3-HYDROXYACYL-COA JRNL TITL 3 DEHYDROGENASE PROVIDE INSIGHTS INTO CATALYTIC MECHANISM. JRNL REF BIOCHEMISTRY V. 38 5786 1999 JRNL REFN ISSN 0006-2960 JRNL PMID 10231530 JRNL DOI 10.1021/BI9829027 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 TITL STRUCTURE OF L-3-HYDROXYACYL-COENZYME A DEHYDROGENASE: REMARK 1 TITL 2 PRELIMINARY CHAIN TRACING AT 2.8-A RESOLUTION REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 84 8262 1987 REMARK 1 REFN ISSN 0027-8424 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.3 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.5 REMARK 3 NUMBER OF REFLECTIONS : 45242 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2272 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 66.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5144 REMARK 3 BIN R VALUE (WORKING SET) : 0.3530 REMARK 3 BIN FREE R VALUE : 0.3740 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 253 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4482 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 88 REMARK 3 SOLVENT ATOMS : 319 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.34 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.37 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.40 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.78 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.500 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.900 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.990 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.810 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3HAD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-DEC-98. REMARK 100 THE RCSB ID CODE IS RCSB000202. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-AUG-98 REMARK 200 TEMPERATURE (KELVIN) : 110.0 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.03 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : APS-1 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48014 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.0 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05800 REMARK 200 FOR THE DATA SET : 7.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.24 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M ADA, PH 6.5, 15-20% PEG 4K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.11500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 83.90500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.01000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 83.90500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.11500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.01000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 5360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -44.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 SER A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 THR A 5 REMARK 465 ALA A 6 REMARK 465 SER A 7 REMARK 465 ALA A 8 REMARK 465 SER A 9 REMARK 465 ALA A 10 REMARK 465 LYS A 11 REMARK 465 HIS A 305 REMARK 465 HIS A 306 REMARK 465 HIS A 307 REMARK 465 HIS A 308 REMARK 465 SER B 1 REMARK 465 SER B 2 REMARK 465 SER B 3 REMARK 465 SER B 4 REMARK 465 THR B 5 REMARK 465 ALA B 6 REMARK 465 SER B 7 REMARK 465 ALA B 8 REMARK 465 SER B 9 REMARK 465 ALA B 10 REMARK 465 LYS B 11 REMARK 465 HIS B 303 REMARK 465 HIS B 304 REMARK 465 HIS B 305 REMARK 465 HIS B 306 REMARK 465 HIS B 307 REMARK 465 HIS B 308 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 82 CG CD OE1 OE2 REMARK 470 HIS A 303 CG ND1 CD2 CE1 NE2 REMARK 470 HIS A 304 CG ND1 CD2 CE1 NE2 REMARK 470 GLU B 82 CG CD OE1 OE2 REMARK 470 LYS B 302 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 70 43.48 -107.87 REMARK 500 ASN A 73 90.34 -176.64 REMARK 500 ALA A 107 59.88 -140.04 REMARK 500 ILE A 108 -169.11 -106.93 REMARK 500 ASN A 146 1.80 -69.23 REMARK 500 PHE A 205 -124.92 56.02 REMARK 500 ILE A 206 -69.01 -101.47 REMARK 500 ASP A 269 64.71 -153.88 REMARK 500 GLU A 296 130.14 -174.26 REMARK 500 HIS A 303 97.11 -50.94 REMARK 500 LYS B 16 -37.10 -132.61 REMARK 500 ASN B 73 81.00 -152.50 REMARK 500 ALA B 107 58.91 -146.52 REMARK 500 GLU B 110 53.04 -68.81 REMARK 500 ALA B 127 170.09 -59.09 REMARK 500 SER B 138 51.68 -105.73 REMARK 500 SER B 143 7.37 -64.89 REMARK 500 ASP B 201 49.03 -67.40 REMARK 500 PHE B 205 -127.32 49.67 REMARK 500 ILE B 206 -69.77 -97.56 REMARK 500 ASP B 269 69.32 -178.98 REMARK 500 GLU B 287 37.21 -73.92 REMARK 500 ASN B 288 46.81 38.44 REMARK 500 LYS B 293 10.61 -66.12 REMARK 500 THR B 294 -2.17 -141.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1032 DISTANCE = 5.12 ANGSTROMS REMARK 525 HOH A1065 DISTANCE = 5.28 ANGSTROMS REMARK 525 HOH A1081 DISTANCE = 5.07 ANGSTROMS REMARK 525 HOH A1088 DISTANCE = 5.50 ANGSTROMS REMARK 525 HOH B 887 DISTANCE = 5.59 ANGSTROMS REMARK 525 HOH B1000 DISTANCE = 5.18 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: ASA REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: ACTIVE SITE RESIDUES REMARK 800 REMARK 800 SITE_IDENTIFIER: ASB REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: ACTIVE SITE RESIDUES REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 350 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 750 REMARK 999 REMARK 999 SEQUENCE REMARK 999 SEQUENCE TO BE PUBLISHED BY O'BRIEN,SIMS,GIBSON,& STRAUSS DBREF 3HAD A 1 302 UNP Q16836 HCDH_HUMAN 13 314 DBREF 3HAD B 1 302 UNP Q16836 HCDH_HUMAN 13 314 SEQADV 3HAD ARG A 125 UNP Q16836 PHE 137 NEW ISOZYME SEQADV 3HAD GLN A 140 UNP Q16836 HIS 152 NEW ISOZYME SEQADV 3HAD ARG B 125 UNP Q16836 PHE 137 NEW ISOZYME SEQADV 3HAD GLN B 140 UNP Q16836 HIS 152 NEW ISOZYME SEQADV 3HAD HIS A 303 UNP Q16836 EXPRESSION TAG SEQADV 3HAD HIS A 304 UNP Q16836 EXPRESSION TAG SEQADV 3HAD HIS A 305 UNP Q16836 EXPRESSION TAG SEQADV 3HAD HIS A 306 UNP Q16836 EXPRESSION TAG SEQADV 3HAD HIS A 307 UNP Q16836 EXPRESSION TAG SEQADV 3HAD HIS A 308 UNP Q16836 EXPRESSION TAG SEQADV 3HAD HIS B 303 UNP Q16836 EXPRESSION TAG SEQADV 3HAD HIS B 304 UNP Q16836 EXPRESSION TAG SEQADV 3HAD HIS B 305 UNP Q16836 EXPRESSION TAG SEQADV 3HAD HIS B 306 UNP Q16836 EXPRESSION TAG SEQADV 3HAD HIS B 307 UNP Q16836 EXPRESSION TAG SEQADV 3HAD HIS B 308 UNP Q16836 EXPRESSION TAG SEQRES 1 A 308 SER SER SER SER THR ALA SER ALA SER ALA LYS LYS ILE SEQRES 2 A 308 ILE VAL LYS HIS VAL THR VAL ILE GLY GLY GLY LEU MET SEQRES 3 A 308 GLY ALA GLY ILE ALA GLN VAL ALA ALA ALA THR GLY HIS SEQRES 4 A 308 THR VAL VAL LEU VAL ASP GLN THR GLU ASP ILE LEU ALA SEQRES 5 A 308 LYS SER LYS LYS GLY ILE GLU GLU SER LEU ARG LYS VAL SEQRES 6 A 308 ALA LYS LYS LYS PHE ALA GLU ASN PRO LYS ALA GLY ASP SEQRES 7 A 308 GLU PHE VAL GLU LYS THR LEU SER THR ILE ALA THR SER SEQRES 8 A 308 THR ASP ALA ALA SER VAL VAL HIS SER THR ASP LEU VAL SEQRES 9 A 308 VAL GLU ALA ILE VAL GLU ASN LEU LYS VAL LYS ASN GLU SEQRES 10 A 308 LEU PHE LYS ARG LEU ASP LYS ARG ALA ALA GLU HIS THR SEQRES 11 A 308 ILE PHE ALA SER ASN THR SER SER LEU GLN ILE THR SER SEQRES 12 A 308 ILE ALA ASN ALA THR THR ARG GLN ASP ARG PHE ALA GLY SEQRES 13 A 308 LEU HIS PHE PHE ASN PRO VAL PRO VAL MET LYS LEU VAL SEQRES 14 A 308 GLU VAL ILE LYS THR PRO MET THR SER GLN LYS THR PHE SEQRES 15 A 308 GLU SER LEU VAL ASP PHE SER LYS ALA LEU GLY LYS HIS SEQRES 16 A 308 PRO VAL SER CYS LYS ASP THR PRO GLY PHE ILE VAL ASN SEQRES 17 A 308 ARG LEU LEU VAL PRO TYR LEU MET GLU ALA ILE ARG LEU SEQRES 18 A 308 TYR GLU ARG GLY ASP ALA SER LYS GLU ASP ILE ASP THR SEQRES 19 A 308 ALA MET LYS LEU GLY ALA GLY TYR PRO MET GLY PRO PHE SEQRES 20 A 308 GLU LEU LEU ASP TYR VAL GLY LEU ASP THR THR LYS PHE SEQRES 21 A 308 ILE VAL ASP GLY TRP HIS GLU MET ASP ALA GLU ASN PRO SEQRES 22 A 308 LEU HIS GLN PRO SER PRO SER LEU ASN LYS LEU VAL ALA SEQRES 23 A 308 GLU ASN LYS PHE GLY LYS LYS THR GLY GLU GLY PHE TYR SEQRES 24 A 308 LYS TYR LYS HIS HIS HIS HIS HIS HIS SEQRES 1 B 308 SER SER SER SER THR ALA SER ALA SER ALA LYS LYS ILE SEQRES 2 B 308 ILE VAL LYS HIS VAL THR VAL ILE GLY GLY GLY LEU MET SEQRES 3 B 308 GLY ALA GLY ILE ALA GLN VAL ALA ALA ALA THR GLY HIS SEQRES 4 B 308 THR VAL VAL LEU VAL ASP GLN THR GLU ASP ILE LEU ALA SEQRES 5 B 308 LYS SER LYS LYS GLY ILE GLU GLU SER LEU ARG LYS VAL SEQRES 6 B 308 ALA LYS LYS LYS PHE ALA GLU ASN PRO LYS ALA GLY ASP SEQRES 7 B 308 GLU PHE VAL GLU LYS THR LEU SER THR ILE ALA THR SER SEQRES 8 B 308 THR ASP ALA ALA SER VAL VAL HIS SER THR ASP LEU VAL SEQRES 9 B 308 VAL GLU ALA ILE VAL GLU ASN LEU LYS VAL LYS ASN GLU SEQRES 10 B 308 LEU PHE LYS ARG LEU ASP LYS ARG ALA ALA GLU HIS THR SEQRES 11 B 308 ILE PHE ALA SER ASN THR SER SER LEU GLN ILE THR SER SEQRES 12 B 308 ILE ALA ASN ALA THR THR ARG GLN ASP ARG PHE ALA GLY SEQRES 13 B 308 LEU HIS PHE PHE ASN PRO VAL PRO VAL MET LYS LEU VAL SEQRES 14 B 308 GLU VAL ILE LYS THR PRO MET THR SER GLN LYS THR PHE SEQRES 15 B 308 GLU SER LEU VAL ASP PHE SER LYS ALA LEU GLY LYS HIS SEQRES 16 B 308 PRO VAL SER CYS LYS ASP THR PRO GLY PHE ILE VAL ASN SEQRES 17 B 308 ARG LEU LEU VAL PRO TYR LEU MET GLU ALA ILE ARG LEU SEQRES 18 B 308 TYR GLU ARG GLY ASP ALA SER LYS GLU ASP ILE ASP THR SEQRES 19 B 308 ALA MET LYS LEU GLY ALA GLY TYR PRO MET GLY PRO PHE SEQRES 20 B 308 GLU LEU LEU ASP TYR VAL GLY LEU ASP THR THR LYS PHE SEQRES 21 B 308 ILE VAL ASP GLY TRP HIS GLU MET ASP ALA GLU ASN PRO SEQRES 22 B 308 LEU HIS GLN PRO SER PRO SER LEU ASN LYS LEU VAL ALA SEQRES 23 B 308 GLU ASN LYS PHE GLY LYS LYS THR GLY GLU GLY PHE TYR SEQRES 24 B 308 LYS TYR LYS HIS HIS HIS HIS HIS HIS HET NAD A 350 44 HET NAD B 750 44 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE FORMUL 3 NAD 2(C21 H27 N7 O14 P2) FORMUL 5 HOH *319(H2 O) HELIX 1 A1 LEU A 25 ALA A 36 1 12 HELIX 2 A2 GLU A 48 LYS A 69 1 22 HELIX 3 A3 PRO A 74 SER A 86 1 13 HELIX 4 A4 ALA A 94 SER A 96 5 3 HELIX 5 A5 VAL A 98 SER A 100 5 3 HELIX 6 A6 LEU A 112 LEU A 122 1 11 HELIX 7 A7 ILE A 141 ALA A 145 1 5 HELIX 8 A8 GLN A 151 ARG A 153 5 3 HELIX 9 A9 GLN A 179 ALA A 191 1 13 HELIX 10 A10 VAL A 207 GLU A 223 1 17 HELIX 11 A11 LYS A 229 ALA A 240 1 12 HELIX 12 A12 PRO A 246 VAL A 253 1 8 HELIX 13 A13 LEU A 255 MET A 268 1 14 HELIX 14 A14 PRO A 273 HIS A 275 5 3 HELIX 15 A15 PRO A 279 ALA A 286 1 8 HELIX 16 B1 LEU B 25 ALA B 36 1 12 HELIX 17 B2 GLU B 48 LYS B 69 1 22 HELIX 18 B3 PRO B 74 SER B 86 1 13 HELIX 19 B4 ALA B 94 SER B 96 1 3 HELIX 20 B5 VAL B 98 SER B 100 5 3 HELIX 21 B6 LEU B 112 ASP B 123 1 12 HELIX 22 B7 THR B 142 ALA B 145 1 4 HELIX 23 B8 GLN B 151 ARG B 153 5 3 HELIX 24 B9 GLN B 179 ALA B 191 1 13 HELIX 25 B10 VAL B 207 GLU B 223 1 17 HELIX 26 B11 LYS B 229 ALA B 240 1 12 HELIX 27 B12 PRO B 246 VAL B 253 1 8 HELIX 28 B13 LEU B 255 GLU B 267 1 13 HELIX 29 B14 PRO B 273 HIS B 275 5 3 HELIX 30 B15 PRO B 279 ALA B 286 1 8 SHEET 1 A 8 HIS A 195 LYS A 200 0 SHEET 2 A 8 LEU A 168 LYS A 173 1 N VAL A 169 O HIS A 195 SHEET 3 A 8 PHE A 154 PHE A 159 -1 N HIS A 158 O GLU A 170 SHEET 4 A 8 ILE A 131 SER A 134 1 N PHE A 132 O ALA A 155 SHEET 5 A 8 LEU A 103 GLU A 106 1 N VAL A 104 O ILE A 131 SHEET 6 A 8 HIS A 17 ILE A 21 1 N THR A 19 O LEU A 103 SHEET 7 A 8 THR A 40 VAL A 44 1 N THR A 40 O VAL A 18 SHEET 8 A 8 ILE A 88 SER A 91 1 N ALA A 89 O VAL A 41 SHEET 1 B 8 HIS B 195 LYS B 200 0 SHEET 2 B 8 LEU B 168 LYS B 173 1 N VAL B 169 O HIS B 195 SHEET 3 B 8 PHE B 154 PHE B 159 -1 N HIS B 158 O GLU B 170 SHEET 4 B 8 ILE B 131 SER B 134 1 N PHE B 132 O ALA B 155 SHEET 5 B 8 LEU B 103 GLU B 106 1 N VAL B 104 O ILE B 131 SHEET 6 B 8 HIS B 17 ILE B 21 1 N THR B 19 O LEU B 103 SHEET 7 B 8 THR B 40 VAL B 44 1 N THR B 40 O VAL B 18 SHEET 8 B 8 ILE B 88 SER B 91 1 N ALA B 89 O VAL B 41 CISPEP 1 ASN A 161 PRO A 162 0 -0.64 CISPEP 2 ASN B 161 PRO B 162 0 -0.70 SITE 1 ASA 2 HIS A 158 GLU A 170 SITE 1 ASB 2 HIS B 158 GLU B 170 SITE 1 AC1 24 GLY A 24 LEU A 25 MET A 26 ASP A 45 SITE 2 AC1 24 GLN A 46 ALA A 107 ILE A 108 VAL A 109 SITE 3 AC1 24 GLU A 110 LYS A 115 ASN A 135 THR A 136 SITE 4 AC1 24 SER A 137 HIS A 158 PHE A 159 HOH A 836 SITE 5 AC1 24 HOH A 901 HOH A 929 HOH A1002 HOH A1016 SITE 6 AC1 24 HOH A1045 HOH A1047 HOH A1067 HOH A1080 SITE 1 AC2 17 GLY B 22 GLY B 24 LEU B 25 MET B 26 SITE 2 AC2 17 ASP B 45 GLN B 46 ALA B 107 ILE B 108 SITE 3 AC2 17 VAL B 109 GLU B 110 LYS B 115 ASN B 135 SITE 4 AC2 17 THR B 136 SER B 137 HIS B 158 PHE B 159 SITE 5 AC2 17 HOH B1093 CRYST1 50.230 86.020 167.810 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019908 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011625 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005959 0.00000 MASTER 348 0 2 30 16 0 13 6 0 0 0 48 END